Serving the Philadelphia-Camden-Wilmington metro area
34 of 154 GLP-1 clinics in Philadelphia prescribe tirzepatide (22% of local providers). Compare pricing, insurance acceptance, and patient reviews to find the right provider.
Philadelphia has a population of 1,603,797 in the Philadelphia-Camden-Wilmington metro area. With a local obesity rate of 33.8%, demand for GLP-1 medications like tirzepatide continues to grow. The city is well-served with 34 providers currently prescribing tirzepatide.
Medicaid coverage: Pennsylvania Medicaid covers GLP-1 medications, which may reduce your out-of-pocket cost for tirzepatide. Contact your plan to verify specific formulary coverage and prior authorization requirements.
Telehealth in Pennsylvania: Pennsylvania permits telehealth prescribing for GLP-1 medications by state-licensed providers. Both audio-visual and audio-only consultations are acceptable for follow-up visits. 11 tirzepatide providers in Philadelphia offer telehealth consultations.
There are 34 clinics in Philadelphia, Pennsylvania that prescribe Tirzepatide (Mounjaro/Zepbound) out of 154 total GLP-1 clinics in the area. 11 of these clinics accept insurance.
Tirzepatide (Mounjaro/Zepbound) programs in Philadelphia typically cost between $377 and $816 per month. Prices depend on dosage, whether you use branded or compounded versions, and your insurance coverage. Pennsylvania Medicaid may help cover costs for eligible patients.
Yes. 11 tirzepatide providers serving Philadelphia offer telehealth consultations. Pennsylvania permits telehealth prescribing for GLP-1 medications by state-licensed providers. Both audio-visual and audio-only consultations are acceptable for follow-up visits. You can complete your consultation via video call and have medication shipped to your home.
Learn about Tirzepatide (Mounjaro/Zepbound) – dosing, side effects, costs, and FDA approval status.
This site is for educational purposes only and is not medical advice. Always consult a healthcare provider before starting any medication. Full disclaimer
Yes. Pennsylvania Medicaid covers GLP-1 medications including tirzepatide. Coverage details and prior authorization requirements vary by plan. Contact your Medicaid provider to verify tirzepatide is on your formulary.
Yes. Mounjaro and Zepbound (brand names for tirzepatide) are FDA-approved for weight management. Your provider will determine the right dosage based on your health history and goals.
GLP-1 Medications
Compare Ozempic, Wegovy, Mounjaro, and more
